Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the ...

Delcath Systems (DCTH) announced the publication of results from subgroup analyses of the phase 3 FOCUS study. The publication was published in the Journal of Cancer Research and Clinical Oncology.

The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...

Delcath Systems announces publication of subgroup analyses of phase 3 FOCUS study of Melphalan/Hepatic Delivery System in patients with unresectable metastatic uveal melanoma Queensbury, New York ...

Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...

Some AI developers have acknowledged the risks of dangerous chatbot usage — sometimes called "AI psychosis" —and say they’re ...

Statins were linked to decreased risk for acute asthma exacerbations in mild asthma and had a significant protective effect in Black patients.

Days of extreme heat were linked to increased mortality risk among veterans with cardiometabolic disease, especially those ...

1 Division of Neonatology, Department of Paediatrics, Centre Hospitalier University Hospital of Lausanne, Lausanne, Switzerland 2 Paediatric Surgery, Department of Paediatrics, University Hospital of ...

In patients with tuberculous meningitis, high-dose rifampin yields no survival advantage over the standard dose.

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...